NCT03256539View on ClinicalTrials.gov

Napping, Sleep, Cognitive Decline and Risk of Alzheimer's Disease

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 12, 2021

Primary Completion Date

January 31, 2024

Study Completion Date

January 31, 2024

Conditions
SleepAlzheimer DiseaseCognitive ImpairmentAgingCBT
Interventions
BEHAVIORAL

Sleep intervention

Behavioral sleep intervention program

BEHAVIORAL

Placebo intervention

Quasi-desensitization intervention for insomnia (which does not include any of the active components of CBT-I but implemented in the same frequency and duration)

Trial Locations (1)

94121

UCSF, San Francisco

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

University of California, San Francisco

OTHER

NCT03256539 - Napping, Sleep, Cognitive Decline and Risk of Alzheimer's Disease | Biotech Hunter | Biotech Hunter